SOFINNOVA VENTURE PARTNERS VII L P [Rocket]

Date Filed	Type	Description
02/14/2018	SC 13D/A	Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
09/05/2017	SC 13D/A	SOFINNOVA VENTURE PARTNERS VII L P reports a 5.8% stake in Coherus BioSciences, Inc.
11/08/2013	SC 13D	SOFINNOVA VENTURE PARTNERS VII L P reports a 14.1% stake in Aerie Pharmaceuticals, Inc.
08/06/2012	SC 13D	HYPERION THERAPEUTICS INC reports a 17.9% stake in Hyperion Therapeutics, Inc.
07/30/2012	SC 13D	Durata Therapeutics, Inc. reports a 13.2% stake in Durata Therapeutics, Inc.
04/09/2012	SC 13D/A	SOFINNOVA VENTURE PARTNERS VII L P reports a 4.7% stake in Amarin Corporation plc
02/01/2012	SC 13D/A	Form SC 13D - General statement of acquisition of beneficial ownership [amend]
01/13/2012	SC 13D/A	Trius Therapeutics Inc reports a 0% stake in Trius Therapeutics, Inc.
12/15/2010	SC 13D/A	SOFINNOVA VENTURE PARTNERS VII L P reports a 13.7% stake in Amarin Corporation plc
12/15/2010	SC 13D/A	Form SC 13D - General statement of acquisition of beneficial ownership [amend]
10/05/2010	SC 13D/A	SOFINNOVA VENTURE PARTNERS VII L P reports a 17.1% stake in Amarin Corporation plc
08/30/2010	SC 13D/A	Form SC 13D - General statement of acquisition of beneficial ownership [amend]
10/27/2009	SC 13D/A	SOFINNOVA VENTURE PARTNERS VII L P reports a 13.8% stake in Amarin Corporation plc
07/27/2009	SC 13D/A	Form SC 13D/A -- General statement of acquisition of beneficial ownership [amend]
07/08/2009	SC 13D	Form SC 13D -- General statement of acquisition of beneficial ownership
05/29/2008	SC 13D	Form SC 13D -- General statement of acquisition of beneficial ownership